Anaptysbio, Inc. · NASDAQ:ANAB
Goldman Sachs Group Inc reported a 5.20% stake in Anaptysbio, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 12, 2025
Goldman Sachs Group Inc reported a 5.20% stake in Anaptysbio, Inc., 1,588,654 shares, as a passive investor on Mar 31, 2025. Filed May 12, 2025 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 1,588,654
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 5.20% | 1,588,654 |
| GOLDMAN SACHS & CO. LLC | 5.20% | 1,588,654 |
Source
Related
- Anaptysbio, Inc.
- Goldman Sachs Group Inc
- Anaptysbio, Inc. shareholders
- Schedule 13G/A · Goldman Sachs Group Inc · Nov 12, 2025
- Form 4 · Renton Hollings · Oct 2, 2026
- Form 4 · Orwin John A · Sep 17, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Form 4 · Schmid John P. · Jun 17, 2026
- Form 4 · Renton Hollings · Jun 17, 2026